Endocrinology and Metabolism

The Korean Endocrine Society (대한내분비학회)
권호 표지

Bone Remodeling and Mineralization

뼈의 재형성 및 무기질화

Shin, Chan-Soo;Cho, Hwa-Young
신찬수;조화영

  • Published : 20051200
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Rossert J, Crombrugghe B: Type I collagen: Structure, synthesis and regulation. In:J. Bilezikian, L. Raisz, and G. Rodan (eds.), Principles of bone biology 1. San Diego, USA: Academic Press, 2002
  2. Gokhale J, Robey P, Boskey A: The biochemistry of bone. In: R. Marcus, D. Feldman, and A. Kelsey (eds.), Osteoporosis 1, pp107-188, San Diego, USA: Academic Press, 2001
  3. Seibel MJ, Woitge HW: Basic principles and clinical applications of biochemical markers of bone metabolism: biochemical and technical aspects. J Clin Densitom 2:299-321, 1999 https://doi.org/10.1385/JCD:2:3:299
  4. Gorski JP: Is all bone the same? Distinctive distributions and properties of non-collagenous matrix proteins in lamellar vs. woven bone imply the existence of different underlying osteogenic mechanisms. Crit Rev Oral Biol Med 9:201-223, 1998 https://doi.org/10.1177/10454411980090020401
  5. Glimcher MJ: Mechanism of calcification: role of collagen fibrils and collagen-phosphoprotein complexes in vitro and in vivo. Anat Rec 224:139-153, 1989 https://doi.org/10.1002/ar.1092240205
  6. Anderson HC: Mineralization by matrix vesicles. Scan Electron Microsc 953-964, 1984
  7. Termine JD, Belcourt AB, Conn KM, Kleinman HK: Mineral and collagen-binding proteins of fetal calf bone. J Biol Chem 256:10403-10408, 1981
  8. Stubbs JT, 3rd, Mintz KP, Eanes ED, Torchia DA, Fisher LW: Characterization of native and recombinant bone sialoprotein: delineation of the mineral-binding and cell adhesion domains and structural analysis of the RGD domain. J Bone Miner Res 12:1210-1222, 1997 https://doi.org/10.1359/jbmr.1997.12.8.1210
  9. Boskey AL: Osteopontin and related phosphorylated sialoproteins: effects on mineralization. Ann N Y Acad Sci 760:249-256, 1995 https://doi.org/10.1111/j.1749-6632.1995.tb44635.x
  10. Frost H. Dynamics of bone remodeling. Bone Biodynamics, pp315. Boston, MA: Little and Brown, 1964
  11. Riggs BL, Wahner HW, Melton LJ, 3rd, Richelson LS, Judd HL, Offord KP: Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest 77:1487-1491, 1986 https://doi.org/10.1172/JCI112462
  12. Genant HK, Cann CE, Ettinger B, Gordan GS: Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 97:699-705, 1982 https://doi.org/10.7326/0003-4819-97-5-699
  13. Rodan GA, Martin TJ: Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif Tissue Int 33:349-351, 1981 https://doi.org/10.1007/BF02409454
  14. Howard GA, Bottemiller BL, Turner RT, Rader JI, Baylink DJ: Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism. Proc Natl Acad Sci U S A 78:3204- 3208, 1981
  15. Locklin RM, Khosla S, Turner RT, Riggs BL: Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J Cell Biochem 89:180-90, 2003 https://doi.org/10.1002/jcb.10490
  16. Enomoto H, Shiojiri S, Hoshi K, Furuichi T, Fukuyama R, Yoshida CA, Kanatani N, Nakamura R, Mizuno A, Zanma A, Yano K, Yasuda H, Higashio K, Takada K, Komori T: Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factorkappaB ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene. J Biol Chem 278:23971-23977, 2003 https://doi.org/10.1074/jbc.M302457200
  17. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G: The molecular clock mediates leptin-regulated bone formation. Cell 122:803-815, 2005 https://doi.org/10.1016/j.cell.2005.06.028
  18. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G: Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514-520, 2005 https://doi.org/10.1038/nature03398
  19. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319, 1997 https://doi.org/10.1016/S0092-8674(00)80209-3
  20. Akatsu T, Murakami T, Ono K, Nishikawa M, Tsuda E, Mochizuki SI, Fujise N, Higashio K, Motoyoshi K, Yamamoto M, Nagata N: Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. Bone 23:495-498, 1998 https://doi.org/10.1016/S8756-3282(98)00141-0
  21. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS: osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260-1268, 1998 https://doi.org/10.1101/gad.12.9.1260
  22. Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, Sato Y, Nakagawa N, Yasuda H, Mochizuki S, Gomibuchi T, Yano K, Shima N, Washida N, Tsuda E, Morinaga T, Higashio K, Ozawa H: Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/ osteoprotegerin. Biochem Biophys Res Commun 247:610-615, 1998 https://doi.org/10.1006/bbrc.1998.8697
  23. Yamamoto M, Murakami T, Nishikawa M, Tsuda E, Mochizuki S, Higashio K, Akatsu T, Motoyoshi K, Nagata N: Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat. Endocrinology 139:4012-4015, 1998 https://doi.org/10.1210/en.139.9.4012
  24. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176, 1998 https://doi.org/10.1016/S0092-8674(00)81569-X
  25. Lum L, Wong BR, Josien R, Becherer JD, Erdjument- Bromage H, Schlondorff J, Tempst P, Choi Y, Blobel CP: Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 274:13613-13618, 1999 https://doi.org/10.1074/jbc.274.19.13613
  26. Wong BR, Josien R, Choi Y: TRANCE is a TNF family member that regulates dendritic cell and osteoclast function. J Leukoc Biol 65:715-724, 1999 https://doi.org/10.1002/jlb.65.6.715
  27. Kong YY, Boyle WJ, Penninger JM: Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. Immunol Cell Biol 77:188-193, 1999 https://doi.org/10.1046/j.1440-1711.1999.00815.x
  28. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM: OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323, 1999 https://doi.org/10.1038/16852
  29. Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ: RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A 97:1566-1571, 2000 https://doi.org/10.1073/pnas.97.4.1566
  30. Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J: RANK is essential for osteoclast and lymph node development. Genes Dev 13:2412-2424, 1999 https://doi.org/10.1101/gad.13.18.2412
  31. Noda M, Camilliere JJ: In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124:2991-2994, 1989 https://doi.org/10.1210/endo-124-6-2991
  32. Filvaroff E, Erlebacher A, Ye J, Gitelman SE, Lotz J, Heillman M, Derynck R: Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development 126:4267-4279, 1999
  33. Sabatini M, Boyce B, Aufdemorte T, Bonewald L, Mundy GR: Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice. Proc Natl Acad Sci U S A 85:5235-5239, 1988 https://doi.org/10.1073/pnas.85.14.5235
  34. Pacifici R, Rifas L, McCracken R, Vered I, McMurtry C, Avioli LV, Peck WA: Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci U S A 86:2398-2402, 1989 https://doi.org/10.1073/pnas.86.7.2398
  35. Felix R, Cecchini MG, Fleisch H: Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127:2592- 2594, 1990 https://doi.org/10.1210/endo-127-5-2592
  36. Pfeilschifter J, Bonewald L, Mundy GR: Characterization of the latent transforming growth factor beta complex in bone. J Bone Miner Res 5:49-58, 1990 https://doi.org/10.1002/jbmr.5650050109
  37. Canalis E, McCarthy T, Centrella M: Growth factors and the regulation of bone remodeling. J Clin Invest 81:277-281, 1988 https://doi.org/10.1172/JCI113318
  38. Canalis E, Pash J, Gabbitas B, Rydziel S, Varghese S: Growth factors regulate the synthesis of insulin-like growth factor-I in bone cell cultures. Endocrinology 133:33-38, 1993 https://doi.org/10.1210/en.133.1.33
  39. Krane SM: Identifying genes that regulate bone remodeling as potential therapeutic targets. J Exp Med 201: 841-843, 2005 https://doi.org/10.1084/jem.20050354
  40. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y,Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML: A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11-19, 2002 https://doi.org/10.1086/338450
  41. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, HeegerS, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML: LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523, 2001 https://doi.org/10.1016/S0092-8674(01)00571-2
  42. Robey PG, Boskey AL. Extracellular matrix and biomineralization of bone. In:M. J. Favus (ed.), Primer on the metabolic bone diseases and disorders of mineral metabolism, pp38-46. Washington D.C.: American Society of Bone and Mineral Research, 2003